# Valley National Bancorp: financial statements, quarterly

VLY · Nasdaq · CIK 714310 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vly.md) · [Financials](/companies/vly/financials.md) · [Filings](/companies/vly/filings.md) · [Insiders](/companies/vly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [401](/filings/0000714310-23-000135.md) | [421 d](/filings/0000714310-24-000065.md) | [435](/filings/0000714310-24-000084.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [53.5](/filings/0000714310-24-000164.md) | [17.4 d](/filings/0000714310-26-000017.md) | [33.2](/filings/0000714310-25-000095.md) | [22.9](/filings/0000714310-25-000147.md) | [28.8](/filings/0000714310-25-000157.md) | [(26.7) d](/filings/0000714310-26-000017.md) | [33.1](/filings/0000714310-26-000027.md) | [39.9](/filings/0000714310-26-000041.md) | [46.6](/filings/0000714310-25-000157.md) | [26.3 d](/filings/0000714310-26-000017.md) | [45.3](/filings/0000714310-26-000027.md) | [49.6](/filings/0000714310-26-000041.md) |
| Net income | $m | [141](/filings/0000714310-24-000164.md) | [71.6 d](/filings/0000714310-26-000017.md) | [96.3](/filings/0000714310-25-000157.md) | [70.4](/filings/0000714310-25-000157.md) | [97.9](/filings/0000714310-25-000157.md) | [116 d](/filings/0000714310-26-000017.md) | [106](/filings/0000714310-26-000041.md) | [133](/filings/0000714310-26-000041.md) | [163](/filings/0000714310-25-000157.md) | [195 d](/filings/0000714310-26-000017.md) | [164](/filings/0000714310-26-000041.md) | [171](/filings/0000714310-26-000041.md) |
| Diluted EPS | $ per share | [0.27](/filings/0000714310-24-000164.md) | not reported | [0.18](/filings/0000714310-25-000095.md) | [0.13](/filings/0000714310-25-000147.md) | [0.18](/filings/0000714310-25-000157.md) | not reported | [0.18](/filings/0000714310-26-000027.md) | [0.22](/filings/0000714310-26-000041.md) | [0.28](/filings/0000714310-25-000157.md) | not reported | [0.28](/filings/0000714310-26-000027.md) | [0.29](/filings/0000714310-26-000041.md) |
| Basic EPS | $ per share | [0.27](/filings/0000714310-24-000164.md) | not reported | [0.18](/filings/0000714310-25-000095.md) | [0.13](/filings/0000714310-25-000147.md) | [0.18](/filings/0000714310-25-000157.md) | not reported | [0.18](/filings/0000714310-26-000027.md) | [0.23](/filings/0000714310-26-000041.md) | [0.28](/filings/0000714310-25-000157.md) | not reported | [0.28](/filings/0000714310-26-000027.md) | [0.30](/filings/0000714310-26-000041.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [61.2](/filings/0000714310-23-000135.md) | [60.9](/filings/0000714310-25-000068.md) | [61.0](/filings/0000714310-24-000084.md) | [62.1](/filings/0000714310-24-000151.md) | [62.1](/filings/0000714310-24-000164.md) | [62.5](/filings/0000714310-26-000017.md) | [61.9](/filings/0000714310-25-000095.md) | [62.7](/filings/0000714310-25-000147.md) | [63.0](/filings/0000714310-25-000157.md) | [64.1](/filings/0000714310-26-000041.md) | [64.5](/filings/0000714310-26-000027.md) | [66.3](/filings/0000714310-26-000041.md) |
| Total liabilities | $bn | [54.6](/filings/0000714310-23-000135.md) | [54.2](/filings/0000714310-25-000068.md) | [54.3](/filings/0000714310-24-000084.md) | [55.3](/filings/0000714310-24-000151.md) | [55.1](/filings/0000714310-24-000164.md) | [55.1](/filings/0000714310-26-000017.md) | [54.4](/filings/0000714310-25-000095.md) | [55.1](/filings/0000714310-25-000147.md) | [55.3](/filings/0000714310-25-000157.md) | [56.3](/filings/0000714310-26-000041.md) | [56.6](/filings/0000714310-26-000027.md) | [58.4](/filings/0000714310-26-000041.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.1](/filings/0000714310-23-000135.md) | [0.9](/filings/0000714310-25-000068.md) | [0.1](/filings/0000714310-24-000084.md) | [0.1](/filings/0000714310-24-000151.md) | [0.1](/filings/0000714310-24-000164.md) | [0.1](/filings/0000714310-26-000017.md) | [0.1](/filings/0000714310-25-000095.md) | [0.2](/filings/0000714310-25-000147.md) | [0.1](/filings/0000714310-25-000157.md) | [0.1](/filings/0000714310-26-000041.md) | [0.1](/filings/0000714310-26-000027.md) | [0.4](/filings/0000714310-26-000041.md) |
| Shareholders' equity | $bn | [6.6](/filings/0000714310-24-000164.md) | [6.7](/filings/0000714310-26-000017.md) | [6.7](/filings/0000714310-25-000157.md) | [6.7](/filings/0000714310-25-000157.md) | [7.0](/filings/0000714310-25-000157.md) | [7.4](/filings/0000714310-26-000041.md) | [7.5](/filings/0000714310-26-000041.md) | [7.6](/filings/0000714310-26-000041.md) | [7.7](/filings/0000714310-25-000157.md) | [7.8](/filings/0000714310-26-000041.md) | [7.8](/filings/0000714310-26-000041.md) | [7.9](/filings/0000714310-26-000041.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [374 d](/filings/0000714310-24-000164.md) | [(279) d](/filings/0000714310-26-000017.md) | [99.5](/filings/0000714310-25-000095.md) | [214 d](/filings/0000714310-25-000147.md) | [(157) d](/filings/0000714310-25-000157.md) | [392 d](/filings/0000714310-26-000017.md) | [(17.1)](/filings/0000714310-26-000027.md) | [159 d](/filings/0000714310-26-000041.md) | [5.2 d](/filings/0000714310-25-000157.md) | [197 d](/filings/0000714310-26-000017.md) | [210](/filings/0000714310-26-000027.md) | [164 d](/filings/0000714310-26-000041.md) |
| Capital expenditure | $m | [22.1 d](/filings/0000714310-24-000164.md) | [4.5 d](/filings/0000714310-26-000017.md) | [3.6](/filings/0000714310-25-000095.md) | [2.7 d](/filings/0000714310-25-000147.md) | [3.3 d](/filings/0000714310-25-000157.md) | [6.4 d](/filings/0000714310-26-000017.md) | [3.0](/filings/0000714310-26-000027.md) | [3.1 d](/filings/0000714310-26-000041.md) | [2.8 d](/filings/0000714310-25-000157.md) | [9.1 d](/filings/0000714310-26-000017.md) | [1.4](/filings/0000714310-26-000027.md) | [3.3 d](/filings/0000714310-26-000041.md) |
| Dividends paid | $m | [55.9 d](/filings/0000714310-24-000164.md) | [55.9 d](/filings/0000714310-26-000017.md) | [57.9](/filings/0000714310-25-000095.md) | [56.3 d](/filings/0000714310-25-000147.md) | [56.1 d](/filings/0000714310-25-000157.md) | [57.9 d](/filings/0000714310-26-000017.md) | [62.9](/filings/0000714310-26-000027.md) | [62.3 d](/filings/0000714310-26-000041.md) | [61.8 d](/filings/0000714310-25-000157.md) | [61.8 d](/filings/0000714310-26-000017.md) | [62.9](/filings/0000714310-26-000027.md) | [61.1 d](/filings/0000714310-26-000041.md) |
| Share repurchases | $m | [0.1 d](/filings/0000714310-24-000164.md) | [(9.2) d](/filings/0000714310-26-000017.md) | [0.0](/filings/0000714310-25-000095.md) | [0.0 d](/filings/0000714310-25-000147.md) | [0.0 d](/filings/0000714310-25-000157.md) | [0.0 d](/filings/0000714310-26-000017.md) | [2.2](/filings/0000714310-26-000027.md) | [2.2 d](/filings/0000714310-26-000041.md) | [12.0 d](/filings/0000714310-25-000157.md) | [46.6 d](/filings/0000714310-26-000017.md) | [51.8](/filings/0000714310-26-000027.md) | [20.1 d](/filings/0000714310-26-000041.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [509](/filings/0000714310-23-000135.md) | [510](/filings/0000714310-24-000084.md) | [509](/filings/0000714310-24-000151.md) | [509](/filings/0000714310-24-000164.md) | [511](/filings/0000714310-25-000095.md) | [510](/filings/0000714310-25-000147.md) | [511](/filings/0000714310-25-000157.md) | [563](/filings/0000714310-26-000027.md) | [562](/filings/0000714310-26-000041.md) | [564](/filings/0000714310-25-000157.md) | [559](/filings/0000714310-26-000027.md) | [557](/filings/0000714310-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 552,605,226 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0000714310-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.